Migraine Management with Alternative Medications

Alternative Triptan Options

The American Academy of Family Physicians recommends rizatriptan as a first alternative triptan due to its faster onset of action, with peak concentration in 60-90 minutes, and availability in an absorbable wafer form, which is beneficial for patients with nausea/vomiting 1
Rizatriptan, naratriptan, zolmitriptan, almotriptan, and frovatriptan are alternative triptan options, with frovatriptan and almotriptan reportedly having more rapid onset of action than sumatriptan 1
Naratriptan has the longest half-life among triptans, which may decrease the chance of recurrence headaches 1

Dihydroergotamine (DHE) is considered for severe migraines, with good evidence for efficacy and safety as monotherapy for acute migraine attacks, and is available in parenteral preparations and as a nasal spray 1
The American Family Physician recommends DHE for severe migraines, but notes it is contraindicated with triptans, beta blockers, pregnancy, and several other conditions 2
NSAIDs are recommended as first-line treatment for mild to moderate migraine attacks, with options including aspirin, ibuprofen, naproxen sodium, and ketorolac 3
IV ketorolac (30mg) is effective for severe migraine with minimal risk of rebound headache 3

The American Family Physician suggests trying any medication for 2-3 headache episodes before abandoning that line of therapy, and matching the characteristics of the drug with the patient's needs and usual headache duration 1
Non-oral routes of administration should be considered when significant nausea or vomiting is present 4

Ergot alkaloids are contraindicated in pregnancy and with chronic use due to oxytocic properties and peripheral vasoconstriction, and triptans are contraindicated in ischemic vascular conditions, vasospastic coronary disease, uncontrolled hypertension, or significant cardiovascular disease 1
The American Family Physician advises against using triptans and ergot derivatives together, and limiting acute treatments to no more than twice weekly to prevent medication overuse headache 2
The American Academy of Family Physicians recommends limiting acute treatments to no more than twice weekly to prevent medication overuse headache 4

The treatment algorithm recommends trying a different triptan (rizatriptan recommended as first alternative) as the first attempt, and considering DHE for severe migraines or NSAIDs for mild-moderate attacks if triptan alternatives fail 2
For patients with significant nausea/vomiting, non-oral routes (intranasal, injectable) or add antiemetics should be considered, and for severe, refractory attacks, IV combination therapy with metoclopramide plus ketorolac may be effective 3
The American Family Physician suggests considering IV combination therapy with metoclopramide plus ketorolac for severe, refractory attacks 3

The American College of Physicians recommends trying a different triptan, specifically rizatriptan combined with an NSAID or acetaminophen, as the next step for an 8-day migraine that failed sumatriptan 5
Individual triptan response varies significantly, and if one triptan fails, a different triptan may still provide relief, as recommended by the American College of Physicians and American Academy of Family Physicians 5

The American College of Physicians' 2025 guideline specifically recommends combination therapy, such as rizatriptan with an NSAID (naproxen 500mg or ibuprofen 400-600mg) or acetaminophen (1000mg), as having greater net benefit than monotherapy 5

Dihydroergotamine (DHE) is appropriate for severe, refractory migraines and has good evidence for efficacy as monotherapy 6
DHE is contraindicated in pregnancy, uncontrolled hypertension, and ischemic vascular disease, and should not be used if the patient has taken a triptan within 24 hours 7

IV metoclopramide (10mg) plus IV ketorolac (30mg) may be considered for severe refractory attacks, with metoclopramide having dual benefits of antiemetic properties and direct antimigraine efficacy 6

The American College of Physicians strongly recommends considering preventive therapy given the prolonged attack and likely frequent episodes 5
Limit acute treatments to no more than 2 days per week to avoid medication overuse headache, and consider a short course of corticosteroids (e.g., prednisone) to break prolonged migraine 5

CGRP antagonists (gepants), such as rimegepant, ubrogepant, or zavegepant nasal spray, and ditan, such as lasmiditan, may be considered as third-line options due to higher cost and less comparative effectiveness data, but have proven efficacy 5